IMplementation and Prospective evAluation of dedicated Cardio-oncology services for prevention, monitoring and Treatment of CardioVascular Diseases in patients living with, through and beyond CANCER (IMPACT-CVD in CANCER trial)
Not Applicable
- Conditions
- cancercardiovascular diseaseCancer - Any cancerCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12624001005549
- Lead Sponsor
- The University of Newcastle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 2100
Inclusion Criteria
1.Patients aged 18 years or over, and diagnosed with cancer; and
2.Planned for anti-cancer therapy, known to cause cardiovascular toxicity
Exclusion Criteria
1.Patients who already have an active follow-up with a cardiologist.
2.Life expectancy <12 months: Oncologic (or other) life expectancy <12 months or any other medical condition (including pregnancy) that results in the belief (deemed by the Chief Investigators) that it is not appropriate for the patient to participate in this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method